Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
2002 4
2003 5
2004 3
2005 7
2006 5
2007 5
2008 5
2009 8
2010 6
2011 7
2012 9
2013 15
2014 11
2015 8
2016 4
2017 6
2018 1
2019 3
2020 5
2021 5
2022 2
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

111 results

Results by year

Filters applied: . Clear all
Page 1
Healing rate of macular edema secondary to branch retinal vein occlusion in two years after initiation of intravitreal ranibizumab later combined with other treatment as needed and characteristics of refractory cases.
Kawakami S, Wakabayashi Y, Watanabe Y, Umazume K, Yamamoto K, Goto H. Kawakami S, et al. Among authors: watanabe y. PLoS One. 2023 Jan 3;18(1):e0278968. doi: 10.1371/journal.pone.0278968. eCollection 2023. PLoS One. 2023. PMID: 36595494 Free PMC article.
Tesidolumab (LFG316) for treatment of C5-variant patients with paroxysmal nocturnal hemoglobinuria.
Nishimura JI, Ando K, Masuko M, Noji H, Ito Y, Mayer J, Griskevicius L, Bucher C, Müllershausen F, Gergely P, Rozenberg I, Schubart A, Chawla R, Rondeau JM, Roguska M, Splawski I, Keating MT, Johnson L, Danekula R, Bagger M, Watanabe Y, Haraldsson B, Kanakura Y. Nishimura JI, et al. Among authors: watanabe y. Haematologica. 2022 Jun 1;107(6):1483-1488. doi: 10.3324/haematol.2020.265868. Haematologica. 2022. PMID: 35263983 Free PMC article. No abstract available.
Cost-Effectiveness Analysis of Tisagenlecleucel for the Treatment of Pediatric and Young Adult Patients with Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia in Japan.
Wakase S, Teshima T, Zhang J, Ma Q, Watanabe Y, Yang H, Qi CZ, Chai X, Xie Y, Wu EQ, Igarashi A. Wakase S, et al. Among authors: watanabe y. Transplant Cell Ther. 2021 Mar;27(3):241.e1-241.e11. doi: 10.1016/j.jtct.2020.12.023. Epub 2020 Dec 26. Transplant Cell Ther. 2021. PMID: 33781519 Free article.
111 results